Product Sales Technical Review Thousand Oaks 
socalTECH
OCTOBER 5, 2015
Thousand Oaks-based Teledyne Technologies said this morning that it is cutting its outlook for the third quarter and full year, due to decline in sales in energy-related products. Teledyne is a diversified provider of aerospace, energy, defense, electronics, imaging, engineered systems, and other products.
Xconomy
AUGUST 5, 2016
Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. Published in January, the technology comes from the lab of Keith Joung, who is an Editas cofounder. SMA has no approved treatments. Regeneron is paying $25 million upfront.
Expert insights. Personalized for you.
100 
Let's personalize your content